DK2828256T5 - Kemisk fremgangsmåde til fremstilling af spiroindoloner og mellemprodukter deraf - Google Patents

Kemisk fremgangsmåde til fremstilling af spiroindoloner og mellemprodukter deraf Download PDF

Info

Publication number
DK2828256T5
DK2828256T5 DK13714246T DK13714246T DK2828256T5 DK 2828256 T5 DK2828256 T5 DK 2828256T5 DK 13714246 T DK13714246 T DK 13714246T DK 13714246 T DK13714246 T DK 13714246T DK 2828256 T5 DK2828256 T5 DK 2828256T5
Authority
DK
Denmark
Prior art keywords
spiroindolones
intermediates
preparation
chemical process
chemical
Prior art date
Application number
DK13714246T
Other languages
Danish (da)
English (en)
Other versions
DK2828256T3 (da
Inventor
Yunzhong Li
Changxue Lin
Jovana Nazor
Thomas Ruch
Shiwei Song
Shangjun Teng
Michael Crowe
Michael Foulkes
Giancarlo Francese
Dominique Grimler
Ernst Kuesters
Kurt Laumen
Derek Smith
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK2828256T3 publication Critical patent/DK2828256T3/da
Publication of DK2828256T5 publication Critical patent/DK2828256T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK13714246T 2012-03-23 2013-03-22 Kemisk fremgangsmåde til fremstilling af spiroindoloner og mellemprodukter deraf DK2828256T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2012000359 2012-03-23
PCT/EP2013/056170 WO2013139987A1 (en) 2012-03-23 2013-03-22 Chemical process for preparing spiroindolones and intermediates thereof

Publications (2)

Publication Number Publication Date
DK2828256T3 DK2828256T3 (da) 2019-10-07
DK2828256T5 true DK2828256T5 (da) 2019-12-09

Family

ID=48048006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13714246T DK2828256T5 (da) 2012-03-23 2013-03-22 Kemisk fremgangsmåde til fremstilling af spiroindoloner og mellemprodukter deraf

Country Status (21)

Country Link
US (1) US9598712B2 (enExample)
EP (2) EP3578557B1 (enExample)
JP (1) JP6117906B2 (enExample)
KR (1) KR102057590B1 (enExample)
CN (1) CN104185634B (enExample)
AP (1) AP2014007906A0 (enExample)
AU (1) AU2013237330C1 (enExample)
BR (1) BR112014022909B1 (enExample)
CA (1) CA2866222C (enExample)
CY (1) CY1122087T1 (enExample)
DK (1) DK2828256T5 (enExample)
ES (2) ES2962530T3 (enExample)
HR (1) HRP20191632T1 (enExample)
HU (1) HUE046421T2 (enExample)
LT (1) LT2828256T (enExample)
MX (1) MX354023B (enExample)
PL (1) PL2828256T3 (enExample)
PT (1) PT2828256T (enExample)
RU (1) RU2662815C2 (enExample)
SI (1) SI2828256T1 (enExample)
WO (1) WO2013139987A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI784255B (zh) 2014-12-18 2022-11-21 瑞士商赫孚孟拉羅股份公司 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
JP2017024992A (ja) * 2015-07-15 2017-02-02 公益財団法人微生物化学研究会 化合物の製造方法
LT3810283T (lt) 2018-06-21 2023-08-25 F. Hoffmann-La Roche Ag 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti
CN111041015B (zh) * 2019-12-31 2022-03-18 浙江工业大学 一种高温下制备(r)-(+)-n-乙酰基-1-甲基-3-苯丙胺的方法
US11788071B2 (en) 2020-04-10 2023-10-17 Codexis, Inc. Engineered transaminase polypeptides
CN116209754A (zh) * 2020-09-28 2023-06-02 科德克希思公司 用于合成手性胺的工程化生物催化剂及方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2947758A (en) * 1959-04-28 1960-08-02 Searle & Co 3-(omega-hydrazino) alkylindoles
GB974895A (en) * 1961-04-06 1964-11-11 Parke Davis & Co Process for the production of amine compounds
GB974893A (en) * 1961-04-06 1964-11-11 Parke Davis & Co Amine compounds and means of producing the same
US3183170A (en) * 1961-10-03 1965-05-11 Sanraku Ocean Kabushiki Kaisha Method of l-amino acid manufacture
BE795457A (fr) * 1972-02-16 1973-08-16 Clin Midy Amines indoliques, leur preparation et leur application en therapeutiques
US4073795A (en) * 1976-06-22 1978-02-14 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4331818A (en) * 1980-03-19 1982-05-25 The Procter & Gamble Company Chiral phospine ligand
DE3307095A1 (de) * 1983-03-01 1984-09-06 Degussa Ag, 6000 Frankfurt Mikrobiologisch hergestellte l-phenylalanin-dehydrogenase, verfahren zu ihrer gewinnung und ihre verwendung
US4518692A (en) * 1983-09-01 1985-05-21 Genetics Institute, Inc. Production of L-amino acids by transamination
DE3482982D1 (de) * 1983-09-01 1990-09-20 Genetics Inst Herstellung von l-aminosaeuren durch transaminierung.
US4859591A (en) * 1984-07-05 1989-08-22 W. R. Grace & Co.-Conn. Transamination process for producing amino acids
US4826766A (en) * 1985-09-23 1989-05-02 Genetics Institute, Inc. Production of amino acids using coupled aminotransferases
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
US7541091B2 (en) 2004-05-18 2009-06-02 M & G Usa Corporation Compartmentalized resin pellets for oxygen scavenging
JPWO2006038520A1 (ja) * 2004-10-05 2008-05-15 味の素株式会社 ヒドロキシイミノ酸からのアミノ酸誘導体製造方法
WO2008050207A1 (en) * 2006-10-25 2008-05-02 Pfizer Limited Heterocyclic compounds useful as anabolic agents for livestock animals
EP2132322A4 (en) 2007-03-02 2013-02-20 Richmond Chemical Corp METHOD FOR INCREASING YIELD AND IMPROVING PURIFICATION OF PRODUCTS FROM REACTIONS WITH TRANSAMINASE
EP2285808B1 (en) * 2008-04-29 2013-11-20 Novartis AG Spiro-indole derivatives for the treatment of parasitic diseases
AT507050B1 (de) * 2008-06-17 2010-06-15 Angewandte Biokatalyse Kompete Verfahren zur herstellung von aminen unter verwendung von omega-transaminasen
HUE036104T2 (hu) 2009-01-08 2018-06-28 Codexis Inc Transzamináz polipeptidek
JP5999565B2 (ja) * 2010-07-14 2016-09-28 ディーピーエックス ホールディングス ビー.ブイ. (r)−選択的アミノ化
WO2013142770A1 (en) * 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs

Also Published As

Publication number Publication date
CN104185634A (zh) 2014-12-03
ES2748460T3 (es) 2020-03-16
EP3578557A1 (en) 2019-12-11
SI2828256T1 (sl) 2019-11-29
PL2828256T3 (pl) 2019-12-31
AU2013237330C1 (en) 2016-08-25
AP2014007906A0 (en) 2014-08-31
RU2662815C2 (ru) 2018-07-31
LT2828256T (lt) 2019-09-25
EP3578557B1 (en) 2023-09-20
KR20140137374A (ko) 2014-12-02
PT2828256T (pt) 2019-10-18
HUE046421T2 (hu) 2020-02-28
JP2015512381A (ja) 2015-04-27
EP2828256A1 (en) 2015-01-28
WO2013139987A1 (en) 2013-09-26
BR112014022909B1 (pt) 2021-11-03
DK2828256T3 (da) 2019-10-07
HK1202289A1 (en) 2015-09-25
BR112014022909A2 (pt) 2017-07-18
CN104185634B (zh) 2017-05-03
HRP20191632T1 (hr) 2019-12-13
CY1122087T1 (el) 2020-11-25
ES2962530T3 (es) 2024-03-19
AU2013237330A1 (en) 2014-09-25
MX354023B (es) 2018-02-08
US9598712B2 (en) 2017-03-21
EP2828256B1 (en) 2019-07-03
MX2014011489A (es) 2015-05-11
AU2013237330B2 (en) 2015-12-03
US20150045562A1 (en) 2015-02-12
JP6117906B2 (ja) 2017-04-19
CA2866222C (en) 2022-01-11
KR102057590B1 (ko) 2019-12-19
RU2014142621A (ru) 2016-05-20
CA2866222A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2718404T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrider
DK2879718T3 (da) Proces til fremstilling af kulhydratkonjugerede RNA-stoffer
DK2804587T3 (da) Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed
DK3725807T3 (da) Anti-cd47 antistoffer og fremgangsmåder til anvendelse deraf
DK2914627T3 (da) Anti-cd40-antistoffer og fremgangsmåder til anvendelse
DK3238709T3 (da) Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme
EP2850106A4 (en) BISPECIFIC SCFV IMMUNOFUSION (BIF)
DK3689853T3 (da) Fremgangsmåde til syntese af thyreoideahormonanaloger og polymorfer deraf
DK3141548T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af azaindoler
DK3824991T3 (da) Fremgangsmåde til forberedelse af lithiumsulfat
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2919923T3 (da) Holder-sortiment og rengøringsapparater til rengøring af åndedrætsapparater
DK2809795T3 (da) Materialer og fremgangsmåder til syntese af fejlminimerede nukleinsyremolekyler
DK2768796T3 (da) Fremgangsmåde til fremstilling af quinolin-derivater
DK2861240T3 (da) Nukleinsyrer til behandling af allergier
DK3050883T3 (da) Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
DK3077513T5 (da) Sammensætninger og fremgangsmåder til fremstilling af (r)-retikulin og udgangsstoffer deraf
DK3210978T3 (da) Fremgangsmåde til fremstilling af acesulfamkalium
DK2627656T3 (da) Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf
DK3299356T3 (da) Fremgangsmåde til fremstilling af pleuromutiliner
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2670591T4 (da) Strukturelement og fremgangsmåde til dets fremstilling
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer